- Ph.D. University of North Carolina at Chapel Hill
A UNC Chapel Hill Ph.D. graduate who is the founder and CEO of Koya Medical, a team dedicated to transforming chronic lymphatic and venous disease. Andy also serves as Chairman and board director with an eye-care and urology health venture. Previously, he led Oculeve, a first-in-class healthcare venture funded by NEA, KPCB, and Versant to treat ocular disorders with a revolutionary neuromodulation platform. Oculeve was acquired by Allergan Plc.